Qualigen Therapeutics Inc (QLGN)
0.297
-0.01
(-3.85%)
USD |
NASDAQ |
Apr 25, 16:00
0.2996
0.00 (0.00%)
After-Hours: 20:00
Qualigen Therapeutics Total Assets (Quarterly): 2.033M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 2.033M |
| September 30, 2023 | 4.316M |
| June 30, 2023 | 13.15M |
| March 31, 2023 | 15.91M |
| December 31, 2022 | 19.08M |
| September 30, 2022 | 22.96M |
| June 30, 2022 | 26.35M |
| Date | Value |
|---|---|
| March 31, 2022 | 18.71M |
| December 31, 2021 | 22.84M |
| September 30, 2021 | 16.40M |
| June 30, 2021 | 19.89M |
| March 31, 2021 | 25.74M |
| September 30, 2020 | 20.68M |
| June 30, 2020 | 8.679M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
2.033M
Minimum
Dec 2023
26.35M
Maximum
Jun 2022
16.91M
Average
18.90M
Median
Total Assets (Quarterly) Benchmarks
| Marizyme Inc | 36.92M |
| CEL-SCI Corp | 28.71M |
| AIM ImmunoTech Inc | 19.38M |
| IGC Pharma Inc | 11.26M |
| NovaBay Pharmaceuticals Inc | 9.034M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 4.137M |
| Shareholders Equity (Quarterly) | -2.104M |